BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8071714)

  • 1. Ascorbate plays a major role in labeling proteins with technetium-99m.
    Thakur ML
    J Nucl Med; 1994 Sep; 35(9):1566-8. PubMed ID: 8071714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody radiolabeling with technetium-99m].
    Perera A; Pérez C
    Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled antibodies specific for human blood elements.
    Thakur ML; DeFulvio J
    Prog Clin Biol Res; 1990; 355():281-92. PubMed ID: 2281107
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved protein labeling by stannous tartrate reduction of pertechnetate.
    Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
    J Nucl Med; 1980 Jan; 21(1):59-62. PubMed ID: 7356741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
    Hnatowich DJ; Virzi F; Winnard P; Fogarasi M; Rusckowski M
    J Nucl Med; 1994 Jan; 35(1):127-34. PubMed ID: 8271033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of tobacco on the labelling of red blood cells and plasma proteins with technetium-99m.
    Vidal MV; Gutfilen B; da Fonseca LM; Bernardo-Filho M
    J Exp Clin Cancer Res; 1998 Mar; 17(1):41-6. PubMed ID: 9646232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.
    Surfraz MB; Biagini SC; Blower PJ
    Dalton Trans; 2008 Jun; (22):2920-2. PubMed ID: 18493625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc labeling of highly potent small peptides.
    Liu S; Edwards DS; Barrett JA
    Bioconjug Chem; 1997; 8(5):621-36. PubMed ID: 9327124
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
    Zhang ZM; Ballinger JR; Sheldon K; Boxen I
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for labeling monoclonal antibodies and antibody-like molecules with technetium-99m.
    Delmon-Moingeon LI; Mahmood A; Davison A; Jones AG
    J Nucl Biol Med (1991); 1991; 35(1):47-59. PubMed ID: 1932176
    [No Abstract]   [Full Text] [Related]  

  • 11. Labeling of antibodies with technetium-99m.
    Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 1993 Sep; 34(9):1617-9. PubMed ID: 8257506
    [No Abstract]   [Full Text] [Related]  

  • 12. Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
    Teng B; Bai Y; Chang Y; Chen S; Li Z
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3440-4. PubMed ID: 17449246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
    Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
    Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
    Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
    Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of redox polymers for insulin labeling with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of the use of radioactively labeled metabolites of hemoglobin-bilirubin for testing liver function. 1. Labeling of bilirubin with 99m technetium].
    Kämpfer I; Blottner A; Schneider G; Deckart H
    Radiol Diagn (Berl); 1988; 29(3):471-6. PubMed ID: 3186964
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
    Sobal G; Resch U; Tatzber F; Sinzinger H
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of four techniques for labeling albumin microspheres with technetium-99m.
    Mayron LW; Kaplan E
    Int J Nucl Med Biol; 1975 Mar; 2(2):74-80. PubMed ID: 1176265
    [No Abstract]   [Full Text] [Related]  

  • 19. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
    Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
    Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of available in vitro 99mTc-RBC labeling techniques: a Canadian perspective.
    Toda E; Ginj M
    J Nucl Med Technol; 2014 Dec; 42(4):243-4. PubMed ID: 25472511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.